Exports of bulk drugs from India have been growing in double digits during the financial year 2019. This period that was marked by drug shortages in the global market because of supply disruptions in China. The domestic market in India was also affected by shortages of bulk drugs as, the pharma industry depends on imports from China.
According to data from the Pharmaceutical Exports Promotion Council (Pharmexcil), exports of bulk drugs and intermediates in FY19 stood at $3.9 billion, up 10.5 per cent over the previous year. The bulk category contributes about 20.3 per cent of India’s overall pharmaceutical exports.
